Obesity
📧 Sign up to get email alerts when something new happens for Obesity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Update: A Study of HS-20094 in Chinese Adults With Overweight or Obesity [Phase 3]
Phase 3 trial update for HS-20094 in Chinese adults with overweight or obesity has completed.
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Update: Lifestyle Interventions for Expectant Mothers (LIFE-Moms Phoenix) - Phoenix [Phase 3]
A Phase 3 trial assessing lifestyle interventions for expectant mothers (LIFE-Moms Phoenix) completed, evaluating effects on obesity-related…
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Results: Effect of Obesity on Proton Pump Inhibitors [Phase 4]
Phase 4 trial assessing the effect of obesity on proton pump inhibitors in pediatric obesity and NAFLD with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Update: A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN) [Phase 3]
Phase 3 trial update for orforglipron (ATTAIN-MAINTAIN) evaluating maintenance of body weight reduction in adults with obesity or overweight…
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: A Study of HS-20094 in Chinese Adults With Overweight or Obesity [Phase 3]
Phase 3 clinical trial update for HS-20094 in Chinese adults with overweight or obesity has completed recruitment.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight [Phase 3]
Phase 3 study of retatrutide (LY3437943) in participants with obesity or overweight has completed enrollment and is reporting results.
-
CLINICAL_TRIALS research · 2026-04-29Clinical Trial Update: Lifestyle Interventions for Expectant Mothers (LIFE-Moms Phoenix) - Phoenix [Phase 3]
A Phase 3 clinical trial evaluating lifestyle interventions for expectant mothers to address obesity-related outcomes.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight [Phase 3]
Phase 3 trial assessing semaglutide for weight loss in adults with obesity and type 2 diabetes completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Results: A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight [Phase 3]
Phase 3 trial results evaluating semaglutide for weight loss in adults with obesity and type 2 diabetes were completed and results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight [Phase 3]
A Phase 3 study completed evaluating semaglutide for weight loss in people with obesity and type 2 diabetes, with results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight [Phase 3]
A Phase 3 trial investigating the weight loss effect of NNC0487-0111 in adults with overweight/obesity and type 2 diabetes (recruiting).
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity [Phase 2]
Phase 2 trial update evaluating the efficacy and safety of different doses of NNC0662-0419 in overweight and obesity.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Aleniglipron Phase 2 in Type 2 Diabetes Mellitus [Phase 2]
Phase 2 clinical trial update for aleniglipron in obesity-related type 2 diabetes mellitus is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain [Phase 3]
Phase 3 clinical trial investigating NNC0487-0111 for weight loss and knee OA pain reduction in adults with obesity and knee osteoarthritis;…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Investigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity With Type 2 Diabetes [Phase 2]
A Phase 2 clinical trial investigating quercetin's effect on glucose absorption in individuals with obesity and obesity-associated type 2 di…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes [Phase 3]
An update on a Phase 3 master protocol evaluating Orforglipron (LY3502970) for obesity or overweight in participants with and without Type 2…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women [Phase 1]
Phase 1 pharmacokinetic study evaluating vitamin E (tocopherol) absorption and biomarkers in normal-weight and obese women.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight [Phase 3]
Phase 3 trial of Survodutide (BI 456906) in overweight or obese adults with Type 2 diabetes has completed, with an update on the study statu…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
The NHLBI-funded clinical trial aims to characterize patients with uncommon cardiovascular presentations and diseases, including obesity-rel…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: The ISAR InflEx Trial (Inflammation and Exercise) [NA]
The ISAR InflEx trial, sponsored by the Department of Cardiology at German Heart Center Munich and TUM University Hospital, is currently rec…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism
The National Institute of Diabetes and Digestive and Kidney Diseases announces a clinical study to examine how perceptions of unpredictabili…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Hormonal Control of Energy and Macronutrient Intake in Obesity (MEMORY) [NA]
This clinical trial update indicates that the MEMORY study, investigating hormonal control of energy and macronutrient intake in obesity, is…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Eating Window and Sleep Disorders on Glycemic Control, Cardiovascular Risk, and Weight Loss [NA]
A clinical trial update from a Brazilian university examining how eating window schedules and sleep disorders influence glycemic control, ca…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight [Phase 2]
This clinical trial update announces a Phase 2 study evaluating the efficacy and safety of Maridebart Cafraglutide in adults with obesity or…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes [Phase 3]
A Phase 3 clinical trial is evaluating Enicepatide (RO7795068) for obesity/overweight without type 2 diabetes; the study is currently recrui…